SG11201708345XA - 5'-substituted nucleoside analogs - Google Patents
5'-substituted nucleoside analogsInfo
- Publication number
- SG11201708345XA SG11201708345XA SG11201708345XA SG11201708345XA SG11201708345XA SG 11201708345X A SG11201708345X A SG 11201708345XA SG 11201708345X A SG11201708345X A SG 11201708345XA SG 11201708345X A SG11201708345X A SG 11201708345XA SG 11201708345X A SG11201708345X A SG 11201708345XA
- Authority
- SG
- Singapore
- Prior art keywords
- nucleoside analogs
- substituted nucleoside
- substituted
- analogs
- nucleoside
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15382225 | 2015-05-04 | ||
PCT/US2016/029475 WO2016178870A1 (en) | 2015-05-04 | 2016-04-27 | 5'-substituted nucleoside analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201708345XA true SG11201708345XA (en) | 2017-11-29 |
Family
ID=53177322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201708345XA SG11201708345XA (en) | 2015-05-04 | 2016-04-27 | 5'-substituted nucleoside analogs |
Country Status (25)
Country | Link |
---|---|
US (1) | US9840532B2 (ja) |
EP (1) | EP3292128A1 (ja) |
JP (2) | JP6181889B1 (ja) |
KR (1) | KR20170132871A (ja) |
CN (1) | CN107580602A (ja) |
AR (1) | AR104326A1 (ja) |
AU (1) | AU2016258485A1 (ja) |
BR (1) | BR112017020336A2 (ja) |
CA (1) | CA2981097A1 (ja) |
CL (1) | CL2017002637A1 (ja) |
CO (1) | CO2017010727A2 (ja) |
CR (1) | CR20170443A (ja) |
DO (1) | DOP2017000255A (ja) |
EA (1) | EA201792169A1 (ja) |
EC (1) | ECSP17072987A (ja) |
HK (1) | HK1244007A1 (ja) |
IL (1) | IL254409A0 (ja) |
MA (1) | MA42036A (ja) |
MX (1) | MX2017014001A (ja) |
PE (1) | PE20180231A1 (ja) |
PH (1) | PH12017502002A1 (ja) |
SG (1) | SG11201708345XA (ja) |
TN (1) | TN2017000459A1 (ja) |
TW (1) | TWI615400B (ja) |
WO (1) | WO2016178870A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107278205A (zh) * | 2015-02-24 | 2017-10-20 | 辉瑞大药厂 | 用作抗癌药的取代的核苷衍生物 |
EP3574917A4 (en) * | 2017-01-27 | 2020-05-06 | University of Miyazaki | ANTI-DRUG MEDICINE, METHOD FOR SCREENING ON ANTI-DRUG MEDICINE, KIT FOR DETERMINING THE EFFECTIVENESS OF CANCER AND METHOD FOR DETERMINING THE EFFECTIVENESS OF CANCER |
WO2018152501A1 (en) | 2017-02-20 | 2018-08-23 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
US11220524B2 (en) | 2017-02-20 | 2022-01-11 | Prelude Therapeutics Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
WO2018160855A1 (en) | 2017-03-01 | 2018-09-07 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
PT3665179T (pt) | 2017-08-09 | 2021-09-10 | Prelude Therapeutics Inc | Inibidores seletivos da proteína arginina metiltransferase 5 (prmt5) |
JP7328218B2 (ja) * | 2017-10-26 | 2023-08-16 | プレリュード セラピューティクス,インコーポレイティド | タンパク質アルギニンメチルトランスフェラーゼ5(prmt5)の選択的阻害剤 |
AU2018385664B2 (en) | 2017-12-13 | 2022-06-02 | Lupin Limited | Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors |
PL3765461T3 (pl) * | 2018-03-14 | 2024-03-04 | Prelude Therapeutics, Incorporated | Selektywne inhibitory białkowej metylotranserazy argininy 5 (prmt5) |
US10711007B2 (en) | 2018-03-14 | 2020-07-14 | Prelude Therapeutics Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) |
JP7337539B2 (ja) * | 2018-06-21 | 2023-09-04 | メディヴィル・アクチエボラーグ | 白血病療法のための塩基修飾シチジンヌクレオチド |
EP3833669A4 (en) * | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | PRMT5 INHIBITORS |
BR112021015796A2 (pt) * | 2019-02-13 | 2021-10-13 | Prelude Therapeutics, Incorporated | Inibidor seletivo de proteína arginina metiltransferase 5 (prmt5) |
PL3980417T3 (pl) | 2019-06-10 | 2024-03-18 | Lupin Limited | Inhibitory prmt5 |
AU2020371295A1 (en) | 2019-10-22 | 2022-04-28 | Lupin Limited | Pharmaceutical combination of PRMT5 inhibitors |
MX2022006735A (es) | 2019-12-03 | 2022-07-21 | Lupin Ltd | Análogos de nucleósidos sustituidos como inhibidores de la prmt5. |
GB202117230D0 (en) | 2021-11-29 | 2022-01-12 | Argonaut Therapeutics Ltd | Peptide vaccine |
GB202203588D0 (en) | 2022-03-15 | 2022-04-27 | Argonaut Therapeutics Ltd | Cancer diagnostic |
CN116211869B (zh) * | 2022-12-07 | 2023-08-01 | 浙江省肿瘤医院 | 含dna损伤修复抑制剂的药物混合物及混合方法、用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02001753A (es) * | 1999-08-27 | 2002-10-23 | Ribapharm Inc | Analogos de nucleosido de pirrolo [2,3-d]pirimidina. |
NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
WO2011079236A1 (en) | 2009-12-22 | 2011-06-30 | The Ohio State University Research Foundation | Compositions and methods for cancer detection and treatment |
EP2731434A4 (en) | 2011-07-13 | 2014-12-31 | Merck Sharp & Dohme | 5'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES |
JP2016505000A (ja) | 2012-12-21 | 2016-02-18 | エピザイム,インコーポレイティド | Prmt5阻害剤およびその使用 |
US9365555B2 (en) | 2012-12-21 | 2016-06-14 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
WO2014100764A2 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Methods of inhibiting prmt5 |
JP2016505597A (ja) | 2012-12-21 | 2016-02-25 | エピザイム,インコーポレイティド | Prmt5阻害剤およびその使用 |
DK2935222T3 (en) | 2012-12-21 | 2019-01-07 | Epizyme Inc | PRMT5 INHIBITORS AND APPLICATIONS THEREOF |
US9745291B2 (en) | 2012-12-21 | 2017-08-29 | Epizyme, Inc. | PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof |
CN107278205A (zh) | 2015-02-24 | 2017-10-20 | 辉瑞大药厂 | 用作抗癌药的取代的核苷衍生物 |
-
2016
- 2016-04-20 AR ARP160101081A patent/AR104326A1/es unknown
- 2016-04-22 TW TW105112724A patent/TWI615400B/zh not_active IP Right Cessation
- 2016-04-27 WO PCT/US2016/029475 patent/WO2016178870A1/en active Application Filing
- 2016-04-27 KR KR1020177031713A patent/KR20170132871A/ko active Search and Examination
- 2016-04-27 US US15/139,370 patent/US9840532B2/en not_active Expired - Fee Related
- 2016-04-27 MX MX2017014001A patent/MX2017014001A/es unknown
- 2016-04-27 AU AU2016258485A patent/AU2016258485A1/en not_active Abandoned
- 2016-04-27 EP EP16720676.2A patent/EP3292128A1/en not_active Withdrawn
- 2016-04-27 BR BR112017020336-7A patent/BR112017020336A2/pt not_active Application Discontinuation
- 2016-04-27 PE PE2017002330A patent/PE20180231A1/es not_active Application Discontinuation
- 2016-04-27 SG SG11201708345XA patent/SG11201708345XA/en unknown
- 2016-04-27 CN CN201680025080.3A patent/CN107580602A/zh active Pending
- 2016-04-27 EA EA201792169A patent/EA201792169A1/ru unknown
- 2016-04-27 JP JP2016575652A patent/JP6181889B1/ja not_active Expired - Fee Related
- 2016-04-27 CA CA2981097A patent/CA2981097A1/en not_active Abandoned
- 2016-04-27 CR CR20170443A patent/CR20170443A/es unknown
- 2016-04-27 MA MA042036A patent/MA42036A/fr unknown
- 2016-04-27 TN TNP/2017/000459A patent/TN2017000459A1/en unknown
-
2017
- 2017-02-15 JP JP2017025494A patent/JP2017125029A/ja active Pending
- 2017-09-11 IL IL254409A patent/IL254409A0/en unknown
- 2017-10-17 CL CL2017002637A patent/CL2017002637A1/es unknown
- 2017-10-20 CO CONC2017/0010727A patent/CO2017010727A2/es unknown
- 2017-10-30 DO DO2017000255A patent/DOP2017000255A/es unknown
- 2017-11-01 EC ECIEPI201772987A patent/ECSP17072987A/es unknown
- 2017-11-03 PH PH12017502002A patent/PH12017502002A1/en unknown
-
2018
- 2018-03-15 HK HK18103599.9A patent/HK1244007A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2981097A1 (en) | 2016-11-10 |
US9840532B2 (en) | 2017-12-12 |
CO2017010727A2 (es) | 2018-01-31 |
PH12017502002A1 (en) | 2018-03-26 |
AU2016258485A1 (en) | 2017-10-12 |
CN107580602A (zh) | 2018-01-12 |
CR20170443A (es) | 2017-11-07 |
HK1244007A1 (zh) | 2018-07-27 |
US20160326208A1 (en) | 2016-11-10 |
EP3292128A1 (en) | 2018-03-14 |
BR112017020336A2 (pt) | 2019-05-14 |
ECSP17072987A (es) | 2018-02-28 |
TN2017000459A1 (en) | 2019-04-12 |
PE20180231A1 (es) | 2018-01-31 |
TW201712022A (zh) | 2017-04-01 |
MA42036A (fr) | 2018-03-14 |
CL2017002637A1 (es) | 2018-04-20 |
JP2017125029A (ja) | 2017-07-20 |
TWI615400B (zh) | 2018-02-21 |
IL254409A0 (en) | 2017-11-30 |
WO2016178870A1 (en) | 2016-11-10 |
JP6181889B1 (ja) | 2017-08-16 |
KR20170132871A (ko) | 2017-12-04 |
EA201792169A1 (ru) | 2018-03-30 |
JP2017525667A (ja) | 2017-09-07 |
AR104326A1 (es) | 2017-07-12 |
DOP2017000255A (es) | 2018-01-15 |
MX2017014001A (es) | 2018-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1244007A1 (zh) | 5'-取代的核苷類似物 | |
HK1245800A1 (zh) | 被取代的核苷、核苷酸及其類似物 | |
IL273341A (en) | Converted nucleosides, nucleotides and their analogs | |
HK1245279A1 (zh) | 取代的核苷、核苷酸及其類似物 | |
IL249628A0 (en) | Nucleosides, modified nucleotides and their analogs | |
IL249627A0 (en) | Nucleosides, modified nucleotides and their analogs | |
IL254011B (en) | Antiviral compounds | |
HK1249385A1 (zh) | Kegel健康系統 | |
HK1222178A1 (zh) | 取代的核苷、核苷酸及其類似物 | |
GB201511477D0 (en) | Antiviral compounds | |
IL250836A0 (en) | Nucleotide analogs | |
HK1248069A1 (zh) | 去乙酰氧基微管溶素h及其類似物 | |
EP3350191A4 (en) | NUCLEOTIDE ANALOGS | |
IL273387A (en) | Thylanstatin analogs | |
GB201515903D0 (en) | Rowing telemetrics system | |
GB201703369D0 (en) | Antiviral composition | |
SG11202001495VA (en) | Spirothietane nucleosides | |
GB201513601D0 (en) | Antiviral compounds | |
GB201520003D0 (en) | Snowboard | |
IL257122A (en) | Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents | |
GB201514662D0 (en) | Antiviral compounds | |
GB201514477D0 (en) | Antiviral compounds | |
GB201517692D0 (en) | Skis | |
GB201507181D0 (en) | Novel antiviral compounds | |
GB201500897D0 (en) | Novel antiviral compounds |